Presentaties 2016

Speed up! Nieuwe wetenschappelijke inzichten in de strijd tegen hiv/aids uit het NCHIV [New scientific insights into the fight against HIV/AIDS from NCHIV]
Reiss P

Onze soa-hiv bestrijding begint met GIS-werk…! [Our battle against STD-HIV starts with GIS work...!]
Op de Coul E, Joore I et al. 

Oral presentations

The HIV epidemic in the Netherlands: an update
Reiss P
 
Estimating the HIV epidemic on a local level: the HIV care continuum in Amsterdam
Van Sighem A
 
Incidence and risk factors for venous thrombotic events in HIV-infected patients: Data from the Dutch nationwide ATHENA cohort study
Rokx C
 
Integrase inhibitor use is an independent risk factor for immune reconstitution inflammatory syndrome (IRIS) in HIV-1 late presenters in the Dutch ATHENA cohort
Wijting I

Poster presentations

Frequency of STI testing associated with sexual risk behavior and HIV serostatus among MSM in the Netherlands
Reitsema M, Wallinga J, van Benthem BH, van Sighem AI, Schim van der Loeff MF, Xiridou M
 
Health related quality of life of HIV-infected patients in care in the Netherlands: A cross-sectional assessment of patient related factors, and comparison with other chronic diseases
Nieuwkerk P, Engelhard EAN, Smit C
 
Viral load metrics: an additional benefit for HIV surveillance?
Heijne J, Bolijn R, Op de Coul E, van Sighem A, Blok WL,  Kretzschmar ME
 
Increasing role of young MSM to HIV epidemic spread and renewal
Ratmann O, Bezemer D, van Sighem A, Pettersson A, Bierman W, Reiss P, Fraser C, Boucher C
 
Several national HIV-1 non-B subtype sub-epidemics established in the Netherlands
Bezemer D, Ratmann O, van Sighem A, Fraser C, Reiss P
 
Despite a decreasing rate of virological failure in the treated Dutch HIV-infected population, transmitted HIV drug resistance in the Netherlands remains stable
Hofstra LM, van Sighem A, Litsenburg M, Brinkman K, Bierman W, van der Ende ME, Hoepelman AIM, Van Kasteren M, Op de Coul E, Richter C, Boucher CAB, Wensing AMJ
 
HIV infection is independently associated with chronic kidney disease and mild glomerular hyperfiltration, particularly in those of African descent
Kooij K, Vogt L, Wit FWNM, van der Valk M
 
Lack of compliance to hepatocellular carcinoma (HCC) screening guidelines in hepatitis B (HBV) or C (HCV) virus co-infected HIV patients with cirrhosis; COHERE in Eurocoord
Smit C
 
Effect of hepatitis C virus infection and its timing relative to HIV seroconversion on CD4 T-cell and HIV RNA trends among HIV-positive MSM
van Santen D, van der Helm JJ, Touloumi GT, Pantazis NP,  Muga RM, Bartmeyer BB, Gill JG, Sanders ES, Kelleher AK, Zangerle RZ, Porter KP, Prins MP, Geskus RG
 
Development and validation of the HCV-MOSAIC risk score to assist testing for acute HCV infection in HIV-infected MSM
Newsum AM, Stolte IG, van der Meer JTM, Schinkel J, van der Valk M, Vanhommerig JW,  Buvé A, Danta M, Hogewoning A, Prins M, on behalf of the MOSAIC study group
 
The role of CMV and the need for appropriate HIV-uninfected controls to evaluate T-cell senescence in HIV-positive individuals on combination antiretroviral therapy
Booiman T, Wit FW, Girigorie AG, de Francesco D, Sabin WCA, Harskamp AM, Prins M,  de Franceschi C, Deeks SG, Winston A, Reiss P, Kootstra NA

Poster presentations

Increasing ART coverage and viral suppression are associated with a substantial decline in new HIV infections in the Austrian Tyrol
Leierer G, van Sighem A, Sarcletti M, Kitchen M, Gisinger M, Rappold M, Ledergerber B, Zangerle R

Posters

• A comparison of the continuum of HIV care in 11 European countries using standardised methods
  A. Gourlay, A. Amato-Gauci, M. Axelsson, F. Cazein, D. Costagliola, S. Cowan, S. Croxford, A. d’Arminio Monforte, J. del Amo, V. Delpech, A. Díaz, E. Girardi, B. Gunsenheimer-Bartmeyer, V. Hernando, S. Jose, G. Leierer, F. Lot, G. Nikolopoulos, N. Obel, E. Op de Coul, A. Pharris, P. Reiss, C. Sabin, A. Sasse, D. Schmid, A. Sonnerborg, A. Spina, B. Suligoi, V. Supervie, G. Touloumi, D. Van Beckhoven, A. Van Sighem, G. Vourli, R. Zangerle, T. Noori, K. Porter and the European HIV continuum of care working group
• Long-term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand
  Judd A, Chappell E, Doerholt K, Galli L, Giaquinto C, Gibb D, Goetghebuer T, Le Coeur S, Noguera Julian A, Turkova A, Goodall R, European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)  
• Effect of the timing of hepatitis C virus infection, relative to HIV seroconversion on CD4 T cell and HIV RNA evolution among HIV-positive MSM
  Van Santen D, van der Helm J, Touloumi G, Pantazis N, Muga R, Bartmeyer B, Gill J, Sanders E, Kelleher A, Zangerle R, Béguelin C, Porter K, Prins M, Geskus R, on behalf of the CASCADE Collaboration within EuroCoord 
• Virological response to first-line ART in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)
  Goodall RL, Chiappini E, Gibb DM, Klimkait T, Ngo-Giang-Huong N, Thorne C, Turkova A, Judd A, European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) 
• Poor immune response despite virologically suppressive antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord
  Collins IJ, Chappell E, Ene L, Jourdain G, Riordan A, Scherpbier HJ, Warszawski J, Giaquinto C, Gibb DM, on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord 
• Long-term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand
  Judd A, Chappell E, Doerholt K, Galli L, Giaquinto C, Gibb D, Goetghebuer T, Le Coeur S, Noguera Julian A, Turkova A, Goodall R, European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) 
• The epidemiology of perinatally HIV-infected adolescents: a CIPHER cohort collaboration global analysis
  Slogrove A, Judd A, Leroy V, Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration 
• Switching to second-line antiretroviral therapy (ART) in HIV-infected children: a CIPHER cohort collaboration global analysis
  Collins IJ, Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration Duration of First-line Team 

• Viral load metrics: an additional benefit for HIV surveillance? 
  R. Bolijn, E.L.M. Op de Coul, A.I Van Sighem, W.L. Blok, M.E. Kretzschmar, J.C.M. Heijne, on behalf of the ATHENA national observational HIV cohort

Oral presentation

Sources of HIV infection today
van Sighem A

Oral presentations

AIDS Defining Events (ADEs) are associated with Long-Term Risk of Mortality due to non-AIDS defining events (NADEs) among HIV-infected persons on Antiretroviral Therapy (ART)
Pettit A
 
Improved life expectancy of HIV-1 positive patients starting ART between 1996-2010 in Europe
Trickey A
 
Trends in cause-specific mortality; differences by HCV coinfection
Alejos B
 
HIV-replication as independent risk factor for primary and secondary CMV-retinitis, extrapulmonary cryptococcosis and disseminated M.avium disease
Atkinson A
 
Reduction in future burden of cardiovascular disease is larger by interventions targeting traditional cardiovascular risk factors compared to HIV-specific interventions: a modelling study
Smit M
 
Long-term trends in mortality and AIDS-defining events among perinatally HIV-infected children  across Europe and Thailand
Chappell E
 
Lower mortality and better height gain with immediate compared to deferred antiretroviral therapy in children aged 5-10 years, but no difference for adolescents
Davies A
 
Checking inverse probability weights for time-varying HIV treatments via balance of baseline covariates
Caniglia E, Hernan M, Robins J
 
AIDS Defining Events (ADEs) are associated with Long-Term Risk of Mortality due to non-AIDS defining events (NADEs) among HIV-infected persons on Antiretroviral Therapy (ART)
Pettit A, Giganti M, Ingle S,  May M, Shepherd B, Gill J,  Fatkenheuer G,  Abgrall S, Saag M, del Amo J, Justice A, Sterne J, Sterling T on behalf of ARTCC

Posters

HIV infection is independently associated with chronic kidney disease and mild glomerular hyperfiltration, particularly in those of African descent 
Katherine Kooij on behalf of AGEhIV
 
Median CD4 cell count to ART initiation in Sub-Saharan African men and women living in Western Europe compared to native populations: data from COHERE in EuroCoord
Susana Monge on behalf of COHERE in EuroCoord
 
Primary and secondary cardiovascular prevention is suboptimal in both HIV-infected and uninfected participants of the AGEhIV Cohort Study
van Zoest R 
 
The effect of antiretroviral pill burden on clinical outcomes in treatment naive patients with HIV
Young J
 
CD4 cell trajectories in HIV-positive adults developing Kaposi Sarcoma after starting cART: a multiregional comparison based on nested case control studies
Rohner E
 
Is HIV infection duration associated with diabetes mellitus?
Lyons A
 
Virological response to first-line ART in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord
Goodall R
 
Poor immune response despite virologically suppressive antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord
Collins IJ
 
Markers of suboptimal interventions for prevention of mother-to-child transmission by migrant status among HIV-positive women in Europe
Favarato G
 
Using HIV cohort data for calibration of HIV microsimulation models
Murray E, Robins J, SeageG, Freedberg K, Hernan M
 
Comparing dynamic HIV treatment strategies that depend on different sets of biomarkers
Cain L, Hernán M
 
A comparison of TMLE and IP weighting for estimating risks under hypothetical HIV treatment strategies
Swanson S, Petersen M, Schwab J, Hernan M on behalf of HIV-CAUSAL Collaboration

Oral presentations

• Antiretrovirals, fractures, and osteonecrosis in a large European HIV cohort
  Borges AH, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, Janez T, Gargalianos-Kakolyris P, Lundgren JD, Mocroft A; for the for EuroSIDA in EuroCOORD.
• Brain MRI changes associated with poorer cognitive function in treated HIV infection
  Underwood J, Cole JH, Caan MW, Sharp DJ, De Francesco D, Leech R, Sabin C, Majoie CB, Reiss P, Winston A, for the The Co-morBidity in Relation to Aids (COBRA) Collaboration.

Posters

• Increasing role of young MSM to HIV epidemic spread and renewal, Ratmann O, Bezemer D, van Sighem A; Pettersson AM, Schutten M, Bierman WF, Reiss P, Fraser C, for the ATHENA HIV Observational Cohort
• Limited overlap in transmission clusters of HIV and HCV among MSM in the Netherlands
  Vanhommerig J, Bezemer D, van Sighem A, Smit C, van der Meer JT, Rijnders BJ, Arends JE, Prins M, van de Laar TJ, Schinkel J, for the observational ATHENA and MOSAIC cohort studies
• Differences in outbreak size for HIV-1 non-B subtypes amongst MSM in the Netherlands
  Bezemer D, Cori A, Ratmann O, van Sighem A, Reiss P, Fraser C
• When to start antiretroviral therapy in HIV positive persons aged over 50 years
  Lodi S
• Safety of stopping primary T. gondii prophylaxis with suppressed viremia and CD4>100 
  Miro JM, Esteve A, Furrer H, for the Opportunistic Infection Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
• Association of tuberculosis with CD4 recovery and HIV RNA decline on ART in Europe,
  Furrer H,for The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
• Tenofovir and the incidence of hepatocellular carcinoma in HIV/HBV-coinfected persons
  Wandeler G, Kraus D, Reiss P, Peters L, DabisF, Fehr J, van der Valk M, Gjaerde L, Bonnet F, Rauch A
• Differences in predictors for ischaemic and haemorrhagic strokes in HIV+ individuals 
  Hatleberg C, Kamara D, Ryom L, de Wit S, Law M, Reiss P, d’Arminio Monforte A, Lundgren JD, Sabin C, for the The Data Collection on Adverse events of Anti-HIV drugs
• Global burden of cervical cancer in HIV-positive women on antiretroviral therapy
  Rohner E, Butikofer L, Maskew M, Chen YA, Friedman R, Souza GD, Eger M, Bohlius J; for the International Epidemiologic Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord 
• CD4 cell response to first-line cART by HIV type in European Cohort Collaborations
  Wittkop L, Matheron S; for the COHERE in EuroCoord and ACIeV2e study team writing committee
• Antiretrovirals, fractures, and osteonecrosis in a large European HIV cohort
  Borges AH, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, Janez T, Gargalianos-Kakolyris P, Lundgren JD, Mocroft A; for the for EuroSIDA in EuroCOORD.
• Brain MRI changes associated with poorer cognitive function in treated HIV infection
  Underwood J, Cole JH, Caan MW, Sharp DJ, De Francesco D, Leech R, Sabin C, Majoie CB, Reiss P, Winston A, for the The Co-morBidity in Relation to Aids (COBRA) Collaboration.
• Kaposi sarcoma risk in children on ART from Africa, Europe, and Asia
  Rohner E, Bohlius J, on behalf of the International Epidemiologic Databases to Evaluate AIDS Southern Africa, the Collaboration of Observational HIV Epidemiological Research in Europe in EuroCoord, and the TREAT Asia Pediatric HIV Observational Database.
• Risk factors for Hodgkin (HL) and non-Hodgkin lymphoma (NHL) in Europe
  Shepherd L, Borges AH, Bogner J, Horban A, Kuzovatova E, Battegay M, Losso M, Lundgren JD, Mocroft A, for the EuroSIDA in EuroCOORD.
• Risk of Kaposi sarcoma in HIV-positive adults on ART: A global analysis
  Rohner E, Bohlius J, Butikofer L, Maskew M, Chen YMA, Fink V, Achenbach C, Egger M, for the International Epidemiologic Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
• The impact of host genes on the tisk of acquiring hepatitis C virus infection 
  Steba GB, Koekkoek SM, Vanhommerig JW, Brinkman K, van der Meer JT, Prins M, Paxton WA, Molenkamp R, Schinkel J, for the MOSAIC study group and ACS.